Alliancebernstein L.P. Sells 759,605 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Alliancebernstein L.P. lowered its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 9.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,350,489 shares of the company’s stock after selling 759,605 shares during the quarter. Alliancebernstein L.P. owned about 0.09% of Pediatrix Medical Group worth $96,438,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. grew its position in Pediatrix Medical Group by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company’s stock valued at $141,861,000 after acquiring an additional 113,976 shares during the last quarter. State Street Corp boosted its stake in shares of Pediatrix Medical Group by 1.4% during the third quarter. State Street Corp now owns 3,540,791 shares of the company’s stock valued at $41,038,000 after purchasing an additional 50,597 shares during the period. Pacer Advisors Inc. bought a new position in shares of Pediatrix Medical Group in the fourth quarter worth about $35,492,000. Boston Partners increased its stake in Pediatrix Medical Group by 25.2% in the 4th quarter. Boston Partners now owns 1,956,353 shares of the company’s stock worth $25,922,000 after buying an additional 393,600 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in Pediatrix Medical Group by 2.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company’s stock valued at $22,452,000 after buying an additional 45,155 shares in the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Trading Up 2.2 %

Shares of NYSE MD opened at $14.83 on Thursday. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67. The business has a fifty day moving average price of $14.44 and a 200 day moving average price of $13.75. The stock has a market capitalization of $1.27 billion, a P/E ratio of -12.36, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.37 by $0.12. The business had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Equities research analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. UBS Group lifted their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. Truist Financial lifted their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, February 21st. Macquarie started coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 price target on the stock. Finally, StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $17.08.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.